Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.9300
+0.1300 (16.25%)
Apr 16, 2026, 9:50 AM EST

Cell Source Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
541518304364
Market Cap Growth
130.86%-14.99%-40.09%-30.67%-32.39%119.45%
Enterprise Value
652628375068
Last Close Price
0.800.350.460.851.282.00
PB Ratio
-2.93-0.82-1.15-2.37-4.40-8.04
Debt / Equity Ratio
-0.57-0.57-0.60-0.63-0.66-0.60
Net Debt / Equity Ratio
-0.57-0.57-0.60-0.61-0.65-0.57
Net Debt / FCF Ratio
-3.91-3.91-3.99-2.45-1.89-1.64
Quick Ratio
0.010.010.000.020.010.03
Current Ratio
0.020.020.010.030.030.05
Return on Assets (ROA)
-996.60%-996.60%-864.18%-721.27%-655.68%-801.86%
Return on Capital Employed (ROCE)
20.70%20.70%26.80%33.00%40.90%45.80%
Earnings Yield
-10.83%-29.57%-29.64%-17.25%-12.66%-7.13%
FCF Yield
--17.59%-13.08%-10.47%-7.82%-4.34%
Buyback Yield / Dilution
-10.81%-10.81%-8.47%-5.19%-13.81%-2.72%
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.